Melanoma therapy with transdermal mitoxantrone cubic phases

References

• Bisht S, Mizuma M, Feldmann G, et al. (2010). Systemic administration of polymeric nanoparticle-encapsulated curcumin (nanocurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 9:2255–64
   PubMed Web of Science ®Google Scholar
• Cao C, Han Y, Ren Y, et al. (2009). Mitoxantrone-mediated apoptotic b16-f1 cells induce specific anti-tumor immune response. Cell Mol Immunol 6:469–75
   PubMed Web of Science ®Google Scholar
• Dai W, Fan Y, Zhang H, et al. (2015). A comprehensive study of irgd-modified liposomes with improved chemotherapeutic efficacy on b16 melanoma. Drug Deliv 22:10–20
   PubMed Web of Science ®Google Scholar
• Dhawan B, Aggarwal G, Harikumar S. (2014). Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Invest 4:65–76
   PubMedGoogle Scholar
• Du L, Jin Y, Yang J, et al. (2013). A functionalized poly(amidoamine) nanocarrier loading 5-fluorouracil: ph-responsive drug release and enhanced anticancer effect. Anti-Cancer Drugs 24:172–80
   PubMed Web of Science ®Google Scholar
• Gan L, Han S, Shen J, et al. (2010). Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 396:179–87
   PubMed Web of Science ®Google Scholar
• Gogas H, Polyzos A, Kirkwood J. (2013). Immunotherapy for advanced melanoma: fulfilling the promise. Cancer Treat Rev 39:879–85
   PubMed Web of Science ®Google Scholar
• Han S, Shen JQ, Gan Y, et al. (2010). Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharm Sin 31:990–8
   PubMed Web of Science ®Google Scholar
• Heidari M, Asgari D, Barar J, et al. (2013). Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target 21:328–40
   PubMed Web of Science ®Google Scholar
• Kim HP, Bernard L, Berkowitz J, et al. (2012). Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia. Cytomet B Clin Cytomet 82:283–94
   PubMed Web of Science ®Google Scholar
• Kraineva J, Narayanan RA, Kondrashkina E, et al. (2005). Kinetics of lamellar-to-cubic and intercubic phase transitions of pure and cytochrome c containing monoolein dispersions monitored by time-resolved small-angle X-ray diffraction. Langmuir 21:3559–71
   PubMed Web of Science ®Google Scholar
• Kwon TK, Kim JC. (2010). In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex. Int J Pharm 392:268–73
   PubMed Web of Science ®Google Scholar
• Legut M, Lipka D, Filipczak N, et al. (2014). Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies. Int J Nanomed 9:653–68
   PubMed Web of Science ®Google Scholar
• Li D, Caffrey M. (2014). Renaturing membrane proteins in the lipid cubic phase, a nanoporous membrane mimetic. Sci Rep 4:5806. http://dx.doi.org/10.1038/srep05806
   PubMed Web of Science ®Google Scholar
• Li C, Zhao X, Deng C, et al. (2014). Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in l1210 ascitic tumor and exhibits dose-dependent activity saturation effect. Int J Pharm 460:165–72
   PubMed Web of Science ®Google Scholar
• Liu W, Wacker D, Wang C, et al. (2014). Femtosecond crystallography of membrane proteins in the lipidic cubic phase. Phil Trans R Soc B 369:20130314
   PubMed Web of Science ®Google Scholar
• Luo M, Shen Q, Chen J. (2011). Transdermal delivery of paeonol using cubic gel and microemulsion gel. Int J Nanomed 6:1603–10
   PubMed Web of Science ®Google Scholar
• Muhonen TT, Wiklund TA, Blomqvist CP, et al. (1992). Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate. Eur J Cancer 28A:1974–6
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, et al. (2007a). Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Panaretakis T, et al. (2007b). Ecto-calreticulin in immunogenic chemotherapy. Immunol Rev 220:22–34
   PubMed Web of Science ®Google Scholar
• Peng X, Yang Z, Chen M, et al. (2009). Preparation, characterization and content determination of cubic phase gel containing capsaicin. Chin J Clin Mater Med 35:3123–6
   Google Scholar
• Podlecka-Pietowska A, Kochanowski J, Zakrzewska-Pniewska B, et al. (2014). The n-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients. Neurol Neurochir Pol 48:111–15
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Al-Dhfyan A, et al. (2013). Chemoprevention of skin cancer using low hlb surfactant nanoemulsion of 5-fluorouracil: a preliminary study. Drug Deliv. Early Onlnie: 1–8. doi:10.3109/10717544.2013.868557
   Google Scholar
• Solly K, Wang X, Xu X, et al. (2004). Application of real-time cell electronic sensing (rt-ces) technology to cell-based assays. Assay Drug Dev Technol 2:363–72
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Fu YS, Lin YH, et al. (2014). The effect of nanoemulsion as a carrier of hydrophilic compound for transdermal delivery. PLoS One 9:e102850
   PubMed Web of Science ®Google Scholar
• Wegener J, Keese CR, Giaever I. (2000). Electric cell–substrate impedance sensing (ecis) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp Cell Res 259:158–66
   PubMed Web of Science ®Google Scholar
• Wu HB, Huo DF, Jiang XG. (2008). Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system. Acta Pharm Sin 43:450–5
   Google Scholar
• Yang J, Shi Y, Li C, et al. (2014). Phase i clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy. Cancer Chemother Pharmacol 74:637–46
   PubMed Web of Science ®Google Scholar
• Zhang P, Ling G, Pan X, et al. (2012). Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride. Nanomedicine 8:185–93
   PubMed Web of Science ®Google Scholar
• Zuo J, Du L, Li M, et al. (2014). Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs. Int J Pharm 466:76–82
   PubMed Web of Science ®Google Scholar